Clinical toxicology · 1977 · 53 citations · 6 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyNeuropharmacologyPsychopharmacologyAnticholinergic ToxicityAntipsychotic PharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapyCholinergic PharmacologyDelirium PharmacotherapyAnticholinergic DrugsAntipsychotic ActionAntipsychotic Side EffectsAntipsychotic Use In DeliriumBlood-brain Barrier PermeabilityCentral Nervous System Anticholinergic EffectsClozapine PharmacologyPharmacologic Delirium Treatment
Clozapine, a new antipsychotic drug without extrapyramidal side effects and with strong sedating potency, can produce acute symptoms of central anticholinergic toxicity. The authors report that physostigmine, a reversible anticholinesterase agent, which can pass the blood-brain barrier, was effective in reversing the clozapine-induced brain syndrome in two patients. Physostigmine also reduced one patient's tachycardia.
6
Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism
Richard J. Miller, C. Robin Hiley · Nature · 1974 · 384 citations
Medicine, Neuroscience, Pharmacology +14
Robert P. Granacher · Archives of General Psychiatry · 1975 · 192 citations